Bio Accumulated Other Comprehensive Income from 2010 to 2024

BIO Stock  USD 287.02  1.98  0.69%   
Bio Rad Accumulated Other Comprehensive Income yearly trend continues to be very stable with very little volatility. Accumulated Other Comprehensive Income is likely to grow to about -319.2 M this year. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
1985-12-31
Previous Quarter
-336 M
Current Value
-426 M
Quarterly Volatility
224.8 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Check out the analysis of Bio Rad Correlation against competitors.

Latest Bio Rad's Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of Bio Rad Laboratories over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Bio Rad's Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Slightly volatile
   Accumulated Other Comprehensive Income   
       Timeline  

Bio Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean94,483,460
Coefficient Of Variation353.84
Mean Deviation279,805,243
Median198,690,000
Standard Deviation334,317,949
Sample Variance111768.5T
Range1.2B
R-Value(0.59)
Mean Square Error78168.7T
R-Squared0.35
Significance0.02
Slope(44,262,424)
Total Sum of Squares1564758.9T

Bio Accumulated Other Comprehensive Income History

2024-319.2 M
2023-336 M
2022-466.8 M
2021-175.6 M
2020282.5 M
2019-87.3 M
2018-47 M

About Bio Rad Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bio Rad income statement, its balance sheet, and the statement of cash flows. Bio Rad investors use historical funamental indicators, such as Bio Rad's Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although Bio Rad investors may use each financial statement separately, they are all related. The changes in Bio Rad's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Rad's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bio Rad Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bio Rad. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-336 M-319.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Bio Stock

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.797
Earnings Share
(10.68)
Revenue Per Share
90.024
Quarterly Revenue Growth
(0.1)
Return On Assets
0.0169
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.